Status:
COMPLETED
Role of Topical Oxytocin Gel in Post-Menopausal Women
Lead Sponsor:
Al-Azhar University
Collaborating Sponsors:
National Research Centre, Egypt
Conditions:
Menopause Related Conditions
Eligibility:
FEMALE
47-66 years
Phase:
NA
Brief Summary
Aim of the current study: To evaluate the effect of a14 day treatment period with local intravaginal application of an oxytocin-containing gel on vaginal atrophy, psychosexual and psychological/cogni...
Eligibility Criteria
Inclusion
- The women were post-menopausal and were between 47 and 67 years old
- The women's last menstruation had occurred more than one year prior to the study
- The women had an established vaginal atrophy
- The women scored \< 26 in the Female Sexual Function Index (FSFI)
- The women had an active sexual relationship
Exclusion
- Women who smoked
- Women who used hormone replacement therapy
- Women using a vaginal lubricant
- Women having any vaginal bleeding or any breast diseases
- Women having any undiagnosed genitalia disorder
- Women suffering from chronic diseases such as diabetes, hypertension, cardiovascular disease, or psychiatric disease
Key Trial Info
Start Date :
December 1 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
May 31 2021
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT05275270
Start Date
December 1 2020
End Date
May 31 2021
Last Update
March 11 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Al-Galaa Teaching Hospital
Cairo, Egypt